• Thu, July 7, 2022
Joon Lee Upgraded (ADVM) to Strong Buy and Increased Target to $40 on, Jul 7th, 2022
Joon Lee of Truist Securities, Upgraded "Adverum Biotechnologies, Inc." (ADVM) to Strong Buy and Increased Target from $30 to $40 on, Jul 7th, 2022.
Joon, nor any peers, have made any analyst calls on ADVM in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30Like: 👍
